Introduction
Atrial fibrillation (AF) is the most common cardiac arrhythmia, with a purported lifetime risk of 25% in adults over the age of 40.
1,2 Atrial fibrillation is an independent risk factor for ischaemic stroke, conveying a 3-4% annualized absolute risk of stroke, and resulting in significant morbidity and mortality. 3 However, not all patients with AF have equal stroke risk, nor will all patients benefit from oral anticoagulation.
A number of risk stratification models have been used in clinical practice to estimate annual stroke risk in patients with AF, [4] [5] [6] of which the CHA 2 DS 2 -VASc is the most widely used in clinical practice at the present time. The main clinical utility of the CHA 2 DS 2 -VASc score is to detect 'truly low risk' patients who do not require
However, there are a number of limitations with these risk stratification models. Firstly, they are designed to be simple and practical and are based on upstream clinical factors such as age, sex, and diabetes mellitus rather than physiological factors that may predispose to left atrial (LA) thrombus formation. 6, 8 Secondly, these risk scores do not incorporate other risk factors that are known to predict high thrombo-embolic risk, such as echocardiographic, biochemical, or coagulation parameters that may predispose to stasis of blood within the left atrium and appendage. 9, 10 Although severe left ventricular (LV) dysfunction is recognized as a significant adverse predictor for stroke, 11 none of the existing risk scores incorporates other such markers of cardiac function or structure. Finally, a small number of patients identified as low risk by these schema and who are not offered anticoagulation may still go on to develop a stroke, suggesting the need for improved risk stratification beyond clinical variables alone. [12] [13] [14] Speckle tracking echocardiography of the left atrium provides an angle independent and sensitive assessment of LA function throughout the cardiac cycle. The onset of P-wave to A 0 duration on tissue Doppler imaging (PA-TDI), representing the time duration between electrical and mechanical activation of the LA measured on colourcoded TDI, reflects the total atrial activation time and is a surrogate for fibrosis and LA substrate remodelling. 15 We hypothesized that the CHA 2 DS 2 -VASc score reflects the harmful effects of clinical risk factors on the LA leading to electromechanical remodelling which results in increased stroke risk. The present study aimed to identify novel echocardiographic markers of LA function that may provide enhanced risk assessment, especially in AF patients with low CHA 2 DS 2 -VASc scores, for the identification of those at increased risk for stroke who may benefit from systemic anticoagulation.
Methods Patients
Patients were identified from a hospital-based database of all patients who were subsequently referred for electrical cardioversion for AF to our tertiary referral centre from April 1995 until January 2015. The first admissions with AF for all such patients were identified. Atrial fibrillation was diagnosed in accordance with the European Society of Cardiology Guidelines for the Management of Atrial Fibrillation 7 and was classified as paroxysmal, persistent, or permanent. Clinical information was collected based on chart review performed by trained research staff at the time of their first hospital admission including demographic data, medications, cardiac risk factors (hypertension, diabetes mellitus, dyslipidaemia, and smoking history), comorbid medical conditions included in the CHA 2 DS 2 -VASc score (coronary artery disease, heart failure, peripheral artery disease, and complex aortic plaque) and pulmonary disease, sleep apnoea, thyroid disease were collected. The CHA 2 DS 2 -VASc score was additionally calculated for each patient based on a point system in which 2 points were assigned for a history of stroke or transient ischaemic attack (TIA), or age > _ 75 years; and 1 point each was assigned for age 65-74 years, a history of hypertension, diabetes, cardiac failure, vascular disease (myocardial infarction, peripheral artery disease, and complex aortic plaque), and female sex. 6 A condition was coded as present or absent based on any doctor's written statement in the patient's medical record, using the International Classification of Diseases, Tenth Revision (ICD-10) code definitions. 16 If the clinical notes, laboratory values, and medication lists did not contain any evidence of a condition, it was coded as absent. The inclusion of study participants is shown in Figure 1 . Patients with a long-term requirement for anticoagulation, including those with mechanical heart valves or mitral stenosis were excluded, as were patients with congenital heart disease. Furthermore, patients with atrial flutter or atrial tachycardia were excluded. The Institutional Review Board approved this retrospective analysis of clinically acquired data and waived the need for patient written informed consent.
Echocardiography
The first transthoracic echocardiograms performed immediately after the diagnosis of AF were selected for analysis. Echocardiograms within 3 weeks after electrical or pharmacological cardioversion were excluded to avoid the effects of atrial stunning. Where multiple echocardiograms were performed during the admission, preference was given to select the echocardiogram performed while the patient was in sinus rhythm to enable assessment of sinus rhythm-specific echocardiographic parameters. Transthoracic echocardiography was performed in the left lateral decubitus position using a commercially available ultrasound transducer and equipment. All images were digitally stored on hard disks for off-line analysis (EchoPAC, BT13, GE-Vingmed). Standard echocardiographic and Doppler parameters of LV-systolic and -diastolic function including pulsed wave TDI at the septal mitral annulus were measured. The LV ejection fraction was calculated using the Simpson's biplane method of discs. Maximal LA volume was calculated using the Simpson's single plane method of discs in the apical 4-chamber view.
Atrial tissue Doppler imaging
The PA-TDI duration was measured on colour-coded TDI images of the LA obtained in the apical 4-chamber view. The sector width and depth were optimized to obtain the highest possible frame rate. A fixed 8 Â 8 mm region of interest was placed on the lateral LA wall, just above the mitral annulus, to obtain the tracing of mechanical activation in that area. The PA-TDI duration was obtained by measuring the time delay between 
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Strain imaging
Global peak longitudinal strain (GLS) of the left ventricle was measured by two-dimensional (2D) speckle tracking echocardiography in the apical 4-, 2-chamber and long-axis views using appropriate frame rates. Images with suboptimal frame rates were excluded from analysis. The global longitudinal strain (GLS) was calculated from the three peak longitudinal strain curves of the three apical views. During analysis, the endocardial border was manually traced, and the width of the region of interest was adjusted to include the entire myocardium. The software then automatically tracks and accepts segments of good tracking quality and rejects poorly tracked segments, while allowing the observer to manually override its decisions based on visual assessments of tracking quality. Left atrial reservoir, conduit, and booster pump strains were also evaluated using 2D speckle tracking on images obtained in the apical 4-chamber view. The ECG was referenced to the onset of the QRS complex, and the region of interest was adjusted to the thickness of the LA wall. Left atrial reservoir strain (es) was measured as the peak positive longitudinal strain during ventricular systole, whereas the strain during early and late diastole (ee and ea, respectively) correspond to the conduit and booster pump functions ( Figure  3) . 18 Care was taken to avoid images with LA or LV foreshortening.
To define the intra-and inter-observer variability, the LA reservoir strain and PA-TDI measurements were repeated for 10 randomly selected patients >4 weeks apart by the same observer on the same echocardiographic images and by a second independent observer. These tests of reproducibility were represented by the intra-class correlation coefficient and by the mean absolute difference between the repeated measures.
Clinical endpoint and follow-up
Patients were followed by chart review for the occurrence of the combined endpoint of ischaemic stroke or TIA documented on the cardiology department and hospital information systems (EPD-Vision and EZIS; Leiden University Medical Centre, Leiden, The Netherlands). Stroke was defined as rapidly developing clinical signs of cerebral disturbance lasting more than 24 h or featuring cerebral imaging evidence of brain infarction, with no apparent non-vascular cause. 19 Transient ischaemic attack was diagnosed if these clinical signs persisted up to 24 h with no indication of brain infarction on neuro-imaging. 19 
Statistical analysis
Continuous variables were presented as mean ± standard deviation for normally distributed variables and median (25th percentile, 75th percentile) for non-Gaussian variables. Continuous variables were compared with the unpaired Student's t-test and the Wilcoxon rank sum test, as appropriate. Categorical data are summarized as frequencies and percentages and compared using the v 2 test or the Kruskal-Wallis test, as appropriate. Multivariable Cox regression analysis was performed to identify factors independently associated with future stroke or TIA. Clinical and echocardiographic parameters were chosen a priori based on biological plausibility and published studies. 6, 11 Parameters with P-values of <0.2 on univariable analysis were entered into the final multivariable The C-index is the probability that for two patients chosen at random, the patient who had the event first had a higher probability of having the event according to the model, and ranges from 0.5 to 1. Somers' D measures how much the prediction for the dependent variable improves, based on knowing a value of the independent variable, with large values (tending towards -1 or 1) suggesting the model has good predictive ability.
Ideally, the accuracy of a model should be assessed in an independent data set from the same population; however, no large validation data set was available, and thus the bootstrap technique using 10 000 iterations was used to assess for over fitting and correct for optimism in the model. 20 Case elimination was used for missing data. A two-tailed P-value <0.05 was considered statistically significant. Statistical analyses were performed using STATA v12 (STATA Corporation, College Station, TX, USA).
Results
Clinical characteristics
A total of 1361 patients were followed up over a mean duration of 7.9 years. The mean age of the patient population was 65±12 years, with 74% males. There were 28%, 57%, and 1% of patients with paroxysmal, persistent, and permanent AF, respectively. A total of 87% patients underwent successful cardioversion, after which 24% maintained sinus rhythm at long-term follow-up. The baseline clinical characteristics of the patients who developed a stroke or TIA compared to those who did not, are presented in Table 1 . Patients who developed a stroke or TIA were older and a higher proportion of these patients had dyslipidaemia, hypertension, and coronary artery disease, compared to non-stroke patients. In addition, patients who developed a stroke or TIA showed higher frequency of previous TIA or stroke than their counterparts. Patients in the stroke group had less frequent use of anticoagulants, and greater use of antiplatelet agents, compared to the non-stroke group. However, exposure to statins or inhibitors of the renal-angiotensin aldosterone system did not differ between groups. Patients were otherwise similar in terms of their body surface area, cardiac risk factors, other co-morbid medical conditions, medication use, and laboratory parameters, including thyroid function tests. There were 100 patients (7% of the population) who developed an ischaemic stroke or TIA, representing an annualized stroke rate of 0.9%. The incident stroke rate in the year following the first diagnosis of AF was 2.6% in the entire population and higher than the remainder of the follow-up period ( Table 2) . Sixteen per cent of the patients who developed subsequent stroke had CHA 2 DS 2 -VASc score of < _1 compared with 31% of the 1261 patients free of stroke or TIA. The annualized stroke rate in patients with CHA 2 DS 2 -VASc score of < _1 was 0.4%, and the incident stroke rate was 1.2% in the first year following AF diagnosis. Seven of these 16 patients were not commenced on anticoagulation when AF was diagnosed.
Echocardiographic characteristics
Echocardiographic parameters for the two groups of patients are presented in Table 3 . A total of 53% of patients were in sinus rhythm, 46% in AF, and 1% of patients in a paced rhythm at the time of echocardiography. Left ventricular GLS was similarly impaired in both 
Inter-and intra-observer variability
The inter-observer intra-class correlation coefficients were 0.989 (95% CI 0.973-0.995) for LA reservoir strain measurement and 0.991 (95% CI 0.979-0.996) for PA-TDI measurement. The intraclass correlation coefficients for intra-observer variability were 0.997 (95% CI 0.991-0.999) for LA reservoir strain and 0.999 (95% CI 0.990-0.998) for PA-TDI. For inter-observer reproducibility, the mean absolute difference between observers in LA reservoir strain measurements was 1.8% and for PA-TDI was 2.64 ms. For intraobserver reproducibility, the mean absolute difference in LA reservoir strain between the repeated measures was 1.1% and for PA-TDI was 1.64 ms.
Discussion
The present study demonstrated that AF patients who developed a stroke showed more impaired LA function (as reflected by reduced LA reservoir and conduit function and prolonged PA-TDI) at the time of AF diagnosis compared with patients who did not develop a stroke (Take home figure) . Furthermore, LA reservoir strain and PA-TDI were independently associated with stroke after correcting for CHA 2 DS 2 -VASc score, age, and anticoagulant use. In contrast, other echocardiographic measures of systolic and diastolic function such as LV GLS, LVEF, LA volume, mitral inflow velocities, and LV filling pressures were no different between the groups.
Stroke risk and risk stratification schema
There is a large body of literature describing stroke risk in AF patients. However, there is considerable diversity in the reported rates of thrombo-embolic events due to differences in endpoint definitions. 21, 22 Many studies include pulmonary embolism and systemic embolism in addition to stroke and TIA. 6, 12, 23 Evidently, a more inclusive definition will magnify the estimated stroke risk. Our endpoint did not include pulmonary embolism based on the lack of causal data linking this to AF; nor were non-cerebral systemic emboli included. Furthermore, TIA is variably included in endpoint definitions; however, we believe the inclusion of TIA is important due to the same underlying aetiological mechanism, the very high risk of subsequent complete stroke, and the high positive predictive value for detecting patients with a confirmed cerebral event in registry data. 24 In view of this, the annualized stroke rate of 0.9% for all patients, and 0.4% in patients with CHA 2 DS 2 -VASc score of < _1 in the present study was comparable to other studies with similar endpoints, 21 and was lower compared to studies with wider endpoint definitions. 6, 12, 23, 25 Furthermore, the incident stroke rate in our study in the year following the first diagnosis of AF was 2.6% in the entire population; and 1.2% in patients who had a CHA 2 DS 2 -VASc score of < _1. These incident stroke rates were higher than for the remainder of the followup period, emphasizing the need for improved stroke risk stratification beyond the CHA 2 DS 2 -VASc score. Although the CHA 2 DS 2 -VASc score provides a good indication of stroke risk based on common clinical risk factors seen in daily practice, there remains the occurrence of stroke in patients with CHA 2 DS 2 -VASc score < _1 in whom antithrombotic therapy is currently not routinely recommended. 26 Consequently, much recent discussion has focused on refinement of stroke risk assessment.
Identification of additional high-risk features by echocardiography seems the most logical modality to assess this due to its widespread availability and its place as the first-line imaging technique for patients with AF. Various echocardiographic studies have examined the relationship between CHADS 2 /CHA 2 DS 2 -VASc risk stratification schema and LA parameters. 27, 28 This correlation may reflect the harmful effects of clinical risk factors on the left atrium leading to electromechanical remodelling which results in the increased stroke risk. The prognostic value of LA volumes and function on echocardiography in lone AF have been previously shown in the setting of the combined endpoints of cardiovascular events (including cerebral infarction or haemorrhage), and hospitalization/death. 29, 30 The utility of conventional echocardiographic parameters to provide additional risk stratification to clinical risk factors for the endpoint of stroke alone has been previously examined in the setting of non-valvular AF. 31, 32 Left atrial dimension had no predictive value for stroke in these studies when adjusting for age, history of previous stroke, heart failure, diabetes, and hypertension
31
; or when adjusting for gender, systolic blood pressure, impaired LV function, recent heart failure, and fractional shortening <25%. 32 Rather, we propose that adding advanced echocardiographic parameters to the CHA 2 DS 2 -VASc risk stratification schema may improve risk stratification of AF patients.
Advanced echocardiographic assessment of left atrial substrate in non-valvular atrial fibrillation and risk of stroke
Left atrial functional assessment, in particular myocardial deformation imaging, has demonstrated better prognostic power for cardiovascular and thrombo-embolic outcomes and provides a more sensitive reflection of the LA substrate than morphological parameters such as LA volume and LA ejection fraction. 30, 33, 34 In studies of non-valvular AF that examined echocardiograms in patients with stroke vs. patients without, a relationship between more impaired LA reservoir strain with increasing stroke risk has been demonstrated. 35, 36 The PA-TDI, a surrogate for LA fibrosis and atrial remodelling, 15 is an independent predictor of new-onset AF, 37 post-operative AF after cardiac surgery, 38 recurrent AF after electrical cardioversion 39 and catheter ablation, and with improved accuracy compared to LA volume. 17 A longer atrial electromechanical interval as measured by the PA-TDI has been associated with increased stroke rates in a prospective study of 279 anticoagulant-naïve patients who were free of AF recurrences following catheter ablation. 40 The PA-TDI duration also increased the predictive performance of the CHA 2 DS 2 -VASc score in aforementioned study. The present study demonstrated reduced LA reservoir strain and lengthened PA-TDI in patients with, compared to without, stroke despite similar LV function, diastolic function, and LV filling pressures in a broad spectrum of CHA 2 DS 2 -VASc risk patients. We have established that more impaired LA reservoir strain and lengthening of PA-TDI are associated with the risk of stroke independent of CHA 2 DS 2 -VASc score, age, and anticoagulant use. These findings with respect to LA reservoir strain are concordant with previous studies. 36, 41 Obokata et al. 41 demonstrated the incremental value of LA reservoir strain to the CHA 2 DS 2 -VASc score in 82 non-valvular AF stroke patients compared with 204 AF controls. However, those studies used echocardiographic measurements at the time of the stroke/TIA. Our results are novel in demonstrating that these differences in the left atrium are already apparent at the time of diagnosis of AF, the time marker of onset of stroke risk for AF patients. Although stroke risk factors may accumulate over time for patients with AF, initial consideration of oral anticoagulant therapy occurs at the first diagnosis of AF. Furthermore, demonstration of the higher stroke rate in the first year after the initial diagnosis of AF, supports the need for careful risk stratification based on factors present at this point in time, as demonstrated in the present study. Structural remodelling of the LA plays an important role in the initiation and progression of AF, and this may be driven by conventional risk factors for AF such as age, hypertension, coronary artery disease, heart failure, diabetes mellitus, hyperthyroidism; in addition to less well-known risk factors such as chronic obstructive pulmonary disease, obesity, obstructive sleep apnoea, and excessive alcohol use. Consequently, the finding that coronary artery disease and hypertension were more prevalent in stroke patients in the present study is likely contributory. Furthermore, patients with stroke had higher CHA 2 DS 2 -VASc scores. It is likely that the individual components of this score, such as diabetes, hypertension, coronary artery disease, and heart failure, constitute risk markers for vascular events in and of themselves that include, but are not limited to, stroke. However, the contribution of vascular disease to stroke cannot be excluded.
The growing body of evidence for PA-TDI as a surrogate for fibrosis demonstrated on biopsies, 15 and the finding of increased stroke risk with reduced LA reservoir strain and lengthened PA-TDI in this study provide some insights into the pathophysiological mechanisms that underlie this relationship. The development of a fibrotic atrial substrate results in longer atrial conduction times, 42 and this may reduce LA compliance during the LA reservoir phase which results in stasis of blood in the LA and LA appendage, leading to stroke. Although stroke was the primary outcome in the present study, death is a clear competing risk when calculating stroke incidence. It is well known that AF is associated with increased mortality due to the presence of cardiovascular risk factors, structural heart disease, and comorbidities, all of which can increase mortality. However, a recent large study examining causes of death in a large population of AF patients receiving long-term anticoagulation with either dabigatran or warfarin has demonstrated that the majority of these deaths are unrelated to stroke. 43 In view of this, the hazard ratios presented in this study are more important for a young individual compared to an older individual where the attendant risk of dying from unrelated causes is much greater, and thus should be considered when interpreting the results of this and other studies where death is a competing risk.
Conclusion
The assessment of LA reservoir strain and PA-TDI on echocardiography after initial CHA 2 DS 2 -VASc risk assessment provides additional risk stratification for stroke and may be useful to guide decisions regarding anticoagulation for patients upon first diagnosis of AF.
